Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Derivatives Options or other derivatives
  2. 4/A Derivatives Options or other derivatives
  3. 4 Open-market buy Member of 10% owner group bought 2,000 shares at $2.58 ($5,160)
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Member of 10% owner group bought 9,200 shares at $2.34 ($21,528)
  6. 4 Grant or award Director acquired 8,666 shares (grant or award)
  7. 4 Grant or award Director acquired 8,666 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Chief Financial Officer bought 8,500 shares at $3.04 ($25,840)
  13. 4 Open-market buy Chief Financial Officer bought 41,500 shares at $2.92 ($121,180)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Director acquired 60,000 shares (grant or award)
  19. 4 Open-market buy Chief Executive Officer bought 500 shares at an average $3.60 ($1,798)
  20. 4 Open-market buy Member of 10% owner group bought 8,600 shares at an average $4.06 ($34,895)

Page 9 of 17 · 329 filings